Treating Snake Envenomation in India: A Costing Analysis for the Adoption of a Small Molecule Therapeutic
Snake envemonation kills as estimated 50,000 individuals each year in India alone. This extremely high mortality rate is primarily the result of poor availability and deliverance of anti-venom in rural areas. A novel solution to the neglected burden of snake envenomation is the use of small molecule inhibitors. Such compounds have been shown to be efficacious in humans and are potentially cost-effective if they can be delivered below a threshold cost. The purpose of this study is to evaluate the production, distribution and research costs of a single small molecule in clinical setting in Northern India.